A Brief History of Pathogen Detection

The concept of pathogens dates back to Ignaz Semmelweis in the 1840s, who dramatically reduced maternal mortality by advocating hygiene. Today, pathogens—including viruses, bacteria, fungi, prions, protozoa, and viroids—are known as agents capable of causing disease. Understanding and detecting these agents accurately is critical to preventing outbreaks and ensuring proper clinical treatment.


Why Detection Techniques Matter

Accurate pathogen detection plays a vital role in modern healthcare. It enables clinicians to select the right treatments, control transmission, and minimize patient risk. Without effective detection methods, infectious diseases can spread undetected and compromise public health systems.


Lateral Flow Antigen Tests (Rapid Tests)

Lateral flow antigen tests are quick, portable, and user-friendly diagnostic tools. They consist of a sample pad, conjugate pad, test membrane, and wicking pad. When a patient sample contains pathogen proteins—such as the SARS-CoV-2 nucleocapsid protein—the test generates visible results within minutes. These tests are especially useful for early detection, mass screening, and self-testing scenarios.


RT-PCR: The Molecular Gold Standard

RT-PCR remains the most accurate molecular diagnostic tool available. It targets pathogen nucleic acids, amplifying specific sequences to detect even minimal viral loads. GBC’s GB SARS-CoV-2 Real-Time RT-PCR kit (4PCO052E) detects both E genes and ORF1ab genes, which reduces the risk of false negatives and ensures high clinical accuracy.


Integrated Detection Strategies

A combined diagnostic approach offers the best of both worlds. Using antigen rapid tests for initial screening and RT-PCR for confirmatory testing delivers speed, precision, and reliability. This integrated model is central to GBC’s solutions for COVID-19 and other infectious diseases, providing healthcare professionals with the tools needed to manage public health effectively.


Conclusion

By uniting rapid antigen screening with high-sensitivity RT-PCR confirmation, GBC offers a flexible and robust diagnostic ecosystem. These solutions support clinicians in making faster, more confident decisions—helping protect communities and advance healthcare globally.